Tag: Pembrolizumab-Axitinib Association in First-Line Metastatic Renal Cell Carcinoma: Preliminary Results of a Series of Five Patients

Pembrolizumab-Axitinib Association in First-Line Metastatic Renal Cell Carcinoma: Preliminary Results of a Series of Five Patients

Abdelaziz AMMARI*, PhD; Sihem BENSALEM, MD; & Assia BENSALEM, MD, PhD *Medical Oncology Department, Hospital Establishment DIDOUCHE Mourad, Faculty of Medicine, University Constantine 3, Algeria DOI: 10.5281/zenodo.20555635 Introduction: Metastatic renal cell carcinoma (mRCC) remains a disease with a poor prognosis. Read More …